Literature DB >> 8976833

Is rifabutin prophylaxis against Mycobacterium avium complex infection in HIV infection worthwhile? The net impact on patients suggests not.

J M Stephenson1, I G Williams.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8976833      PMCID： PMC1195677          DOI： 10.1136/sti.72.4.272

Source DB:  PubMed          Journal:  Genitourin Med        ISSN： 0266-4348


× No keyword cloud information.
  7 in total

1.  Confidence intervals rather than P values: estimation rather than hypothesis testing.

Authors:  M J Gardner; D G Altman
Journal:  Br Med J (Clin Res Ed)       Date:  1986-03-15

2.  In vivo activities of newer rifamycin analogs against Mycobacterium avium infection.

Authors:  S P Klemens; M H Cynamon
Journal:  Antimicrob Agents Chemother       Date:  1991-10       Impact factor: 5.191

3.  Users' guides to the medical literature. II. How to use an article about therapy or prevention. B. What were the results and will they help me in caring for my patients? Evidence-Based Medicine Working Group.

Authors:  G H Guyatt; D L Sackett; D J Cook
Journal:  JAMA       Date:  1994-01-05       Impact factor: 56.272

4.  Users' guides to the medical literature. II. How to use an article about therapy or prevention. A. Are the results of the study valid? Evidence-Based Medicine Working Group.

Authors:  G H Guyatt; D L Sackett; D J Cook
Journal:  JAMA       Date:  1993-12-01       Impact factor: 56.272

5.  Two controlled trials of rifabutin prophylaxis against Mycobacterium avium complex infection in AIDS.

Authors:  S D Nightingale; D W Cameron; F M Gordin; P M Sullam; D L Cohn; R E Chaisson; L J Eron; P D Sparti; B Bihari; D L Kaufman
Journal:  N Engl J Med       Date:  1993-09-16       Impact factor: 91.245

6.  Recommendations on prophylaxis and therapy for disseminated Mycobacterium avium complex disease in patients infected with the human immunodeficiency virus. Public Health Service Task Force on Prophylaxis and Therapy for Mycobacterium avium Complex.

Authors:  H Masur
Journal:  N Engl J Med       Date:  1993-09-16       Impact factor: 91.245

7.  Bias in treatment assignment in controlled clinical trials.

Authors:  T C Chalmers; P Celano; H S Sacks; H Smith
Journal:  N Engl J Med       Date:  1983-12-01       Impact factor: 91.245
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.